Edgewise Therapeutics, Inc. (NASDAQ:EWTX) has reported a significant transaction by Chief Scientific Officer Russell Alan J, who sold shares in the company
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) reported a significant transaction by one of its top executives, according to a recent SEC filing. Behrad Derakhshan,
In a recent transaction, Joanne M. Donovan, the Chief Medical Officer (CMO) of Edgewise Therapeutics, Inc. (NASDAQ:EWTX), sold shares of the company’s
John R. Moore, the General Counsel of Edgewise Therapeutics, Inc. (NASDAQ:EWTX), a pharmaceutical company, has recently sold a significant amount of company
In a recent move that has caught the attention of investors, R. Michael Carruthers, the Chief Financial Officer of Edgewise Therapeutics, Inc.
By Jamie McGeever (Reuters) – A look at the day ahead in Asian markets. Sugar high or shot in the arm? That’s the question
(Reuters) – Starbucks (NASDAQ:SBUX)’ new CEO Brian Niccol said on a letter on Tuesday that he “deeply respects” the right of the
By David Shepardson WASHINGTON (Reuters) -Elon Musk’s SpaceX must operate at the “highest level of safety,” the head of the U.S. Federal Aviation
(Reuters) – Union workers represented by Teamsters at BorgWarner (NYSE:BWA)’s New York state plant approved a four-year contract with the auto parts
In a recent series of transactions, Berkshire Hathaway Inc . (NYSE:BRKa), the conglomerate headed by famed investor Warren E. Buffett, has
